2015
DOI: 10.1002/gcc.22289
|View full text |Cite
|
Sign up to set email alerts
|

Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer

Abstract: (GENES CHROM CANCER=250 words)Molecular mechanisms underlying coordinated hypermethylation of multiple CpG islands in cancer remain unclear. In particular, expressional and other studies of methyltransferase enzymes have arrived at conflicting results. We focused on DNMT1 and DNMT3B, DNA methyltransferases responsible for (de novo) methylation, and EZH2, histone (H3K27) methyltransferase, and

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 63 publications
0
7
0
Order By: Relevance
“…DNMT3b functions as a de novo methyltransferase that establishes new DNA methylation patterns, 43 over-expression and hyperactivation of DNMT3b, which can result in hypermethylation of promoter CpG islands and gene silence. 44 In the present study, we disclosed that HPostC can induce DNA hypomethylation of the miR-30a promoter and…”
Section: Conflict Of Interestsmentioning
confidence: 50%
“…DNMT3b functions as a de novo methyltransferase that establishes new DNA methylation patterns, 43 over-expression and hyperactivation of DNMT3b, which can result in hypermethylation of promoter CpG islands and gene silence. 44 In the present study, we disclosed that HPostC can induce DNA hypomethylation of the miR-30a promoter and…”
Section: Conflict Of Interestsmentioning
confidence: 50%
“…This last result, which held multiple test correction, was further confirmed in the replication sample. These results are consistent with previous data demonstrating that changes in the methylation levels of a single or a few CpG sites have been associated to complex phenotypes, because they are probably located in specific functional regions; in most cases, including gastric and colon cancer, rheumatoid arthritis and type 1 diabetes, these findings were always related to the regulation of the associated gene (Joensuu et al ., ; Yara et al ., ; Zhao et al ., ). Our results seem to be particularly attractive, because they show a fine remodeling of the methylation profile associated with the biological aging rather than to the chronological age and contribute to better clarify the molecular basis of the interindividual psychophysical vulnerability that characterizes the old age (Liu et al ., ; Bellizzi et al ., ).…”
Section: Discussionmentioning
confidence: 97%
“…33,34 Higher frequency and intensity expression of DNMT1 in the DZ are consistent with the proliferative expansion known to occur in the DZ of GCs. 35 Recent studies have also demonstrated significant associations of DNMT1 with a higher Ki-67 score in other malignancies including breast cancer (n=348; P<0.0001), 36 colorectal cancer (n=14; P=0.014) and endometrial cancer (n=48; P=0.030), 37 while functional studies of Dnmt1-knockout or knockdown murine models have shown significant decrease of Ki-67-positive GC B cells 10 and other cell types. [38][39][40] These results indicate that the frequent coexpression of DNMT1 with Ki-67 in normal B cells appears to be maintained in DLBCL cases, and suggest that DNMT1 enables the proliferation of DLBCL cells in line with our observations of frequent DNMT1 expression in DLBCL mitotic cells as well as the established requirement of DNMT1 in cellular replication.…”
Section: Discussionmentioning
confidence: 99%